Using ‘One Health’ to tackle AMR
26 June 2019
Antimicrobial resistance (AMR) is one of the greatest threats to human health. That’s why, today in the House of Commons, the UKRI Cross Council AMR Initiative is speaking face to face with MPs and decision makers about their ‘One Health’ approach to the problem. But what is this approach? And what does it mean for researchers? Ruth Zadoks, Professor in Molecular Epidemiology at the University of Glasgow, tells us about this important interdisciplinary area of research.
Further reading: Medical Research Council
Author(s): Ruth Zadoks
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
